Patients with Parkinson's disease have a number of specific visual disturbances. These
include changes in colour vision and contrast sensitivity and difficulties with complex visual …

Sleep disorders are among the most common non-motor manifestations in Parkinson's
disease (PD) and have a significant negative impact on quality of life. While sleep disorders …

Parkinson's disease (PD) is associated with excessive beta activity in the basal ganglia.
Brain sensing implants aim to leverage this biomarker for demand-dependent adaptive …

Mild cognitive impairment is common in nondemented Parkinson's disease (PD) patients
and may be a harbinger of dementia. In view of its importance, the Movement Disorder …

Parkinson disease (PD) is an age-related neurodegenerative disorder that affects as many
as 1–2% of persons aged 60 years and older. With the aging of the population, the …

Parkinson's disease (PD) is a common neurodegenerative disorder—a synucleinopathy—
with a prevalence of 160/100 000 in Western Europe rising to 4% of the population over 80 …

Summary of Recommendations: Modifying the sleep environment is recommended for the
treatment of patients with RBD who have sleep-related injury. Level A Clonazepam is …

People with Parkinson's disease (PD) and their care partners frequently report cognitive
decline as one of their greatest concerns. Mild cognitive impairment affects approximately 20 …

Background Identifying factors influencing phenotypic heterogeneity in Parkinson's Disease
is crucial for understanding variability in disease severity and progression. Age and gender …

Although diagnosed by characteristic motor features, Parkinson's disease may be preceded,
and is frequently accompanied by, a wide range of cognitive and neuropsychiatric features …